- Home
- TKLF vs IMNN Comparison
TKLF vs IMNN Comparison
Compare TKLF & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- IMNN
- Stock Information
- Founded
- TKLF 2006
- IMNN 1982
- Country
- TKLF Japan
- IMNN United States
- Employees
- TKLF N/A
- IMNN N/A
- Industry
- TKLF Other Specialty Stores
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- TKLF Consumer Discretionary
- IMNN Health Care
- Exchange
- TKLF Nasdaq
- IMNN Nasdaq
- Market Cap
- TKLF 15.7M
- IMNN 13.6M
- IPO Year
- TKLF 2022
- IMNN 1985
- Fundamental
- Price
- TKLF $3.37
- IMNN $0.88
- Analyst Decision
- TKLF
- IMNN Strong Buy
- Analyst Count
- TKLF 0
- IMNN 2
- Target Price
- TKLF N/A
- IMNN $20.50
- AVG Volume (30 Days)
- TKLF 7.8K
- IMNN 141.9K
- Earning Date
- TKLF 12-18-2024
- IMNN 05-12-2025
- Dividend Yield
- TKLF N/A
- IMNN N/A
- EPS Growth
- TKLF N/A
- IMNN N/A
- EPS
- TKLF 1.70
- IMNN N/A
- Revenue
- TKLF $219,520,631.00
- IMNN N/A
- Revenue This Year
- TKLF N/A
- IMNN N/A
- Revenue Next Year
- TKLF N/A
- IMNN N/A
- P/E Ratio
- TKLF $1.96
- IMNN N/A
- Revenue Growth
- TKLF 32.02
- IMNN N/A
- 52 Week Low
- TKLF $2.00
- IMNN $0.64
- 52 Week High
- TKLF $8.53
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- TKLF 43.97
- IMNN 49.35
- Support Level
- TKLF $3.26
- IMNN $0.86
- Resistance Level
- TKLF $3.50
- IMNN $0.93
- Average True Range (ATR)
- TKLF 0.19
- IMNN 0.05
- MACD
- TKLF -0.02
- IMNN 0.00
- Stochastic Oscillator
- TKLF 23.29
- IMNN 61.00
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.